DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
19don MSN
Doctors may have found an easier way to treat prostate cancer — could become new standard of care
Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, prostate cancer often comes with traditional treatments that cause difficult ...
New Jersey hospitals expand prostate cancer treatment with robotics, proton therapy and precision medicine innovations.
One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...
Predictive value of a pathomics signature in de novo metastatic prostate cancer: An ancillary study of the PEACE-1 phase 3 trial. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
A groundbreaking new study suggests that prostate cancer treatment may soon become faster, simpler, and less disruptive for thousands of men across the United States.
A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose to tumors and healthy ...
Confused about prostate cancer screening? Discover how the PSA test, modern MRI scans, and early detection can help you make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results